Lucene search

K
nvd[email protected]NVD:CVE-2007-6763
HistoryJul 31, 2019 - 6:15 p.m.

CVE-2007-6763

2019-07-3118:15:10
CWE-20
web.nvd.nist.gov

6.5 Medium

CVSS2

Attack Vector

NETWORK

Attack Complexity

LOW

Authentication

SINGLE

Confidentiality Impact

PARTIAL

Integrity Impact

PARTIAL

Availability Impact

PARTIAL

AV:N/AC:L/Au:S/C:P/I:P/A:P

8.8 High

CVSS3

Attack Vector

NETWORK

Attack Complexity

LOW

Privileges Required

LOW

User Interaction

NONE

Scope

UNCHANGED

Confidentiality Impact

HIGH

Integrity Impact

HIGH

Availability Impact

HIGH

CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

8.6 High

AI Score

Confidence

High

0.001 Low

EPSS

Percentile

40.1%

SAS Drug Development (SDD) before 32DRG02 mishandles logout actions, which allows a user (who was previously logged in) to access resources by pressing a back or forward button in a web browser.

Affected configurations

NVD
Node
sassas_drug_developmentRange<32drg02

6.5 Medium

CVSS2

Attack Vector

NETWORK

Attack Complexity

LOW

Authentication

SINGLE

Confidentiality Impact

PARTIAL

Integrity Impact

PARTIAL

Availability Impact

PARTIAL

AV:N/AC:L/Au:S/C:P/I:P/A:P

8.8 High

CVSS3

Attack Vector

NETWORK

Attack Complexity

LOW

Privileges Required

LOW

User Interaction

NONE

Scope

UNCHANGED

Confidentiality Impact

HIGH

Integrity Impact

HIGH

Availability Impact

HIGH

CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

8.6 High

AI Score

Confidence

High

0.001 Low

EPSS

Percentile

40.1%

Related for NVD:CVE-2007-6763